|   
Follow us

Business

Weekend Buzz
More

Top News


China pledged more support for companies and workers adversely affected by US tariffs, according to the readout of a Friday meeting of the Political Bureau of the Communist Party. Policymakers signaled readiness to keep money supply loose by cutting interest rates and the reserve requirement ratio on banks, by accelerate debt issuance and by stabilizing the jobs market. Xinhua news agency said Chinese leaders vowed to "strengthen bottom-line thinking" in policies to support the economy.

Top Business

Leading business executives in the US are expressing mounting unease about the unpredictable nature of trade policies, according to the Wall Street Journal report. Top CEOs from companies like American Airlines, PepsiCo and Procter & Gamble are voicing concerns that policy inconsistencies related to tariffs could negatively impact economic stability and the business investment.

Economy

China's economy is off to a solid start this year and continues to improve, People's Bank of China chief Pan Gongsheng said at an annual meeting of the IMF and World bank in Washington. He reiterated the nation's moderately loose" monetary policy to support growth and warned that trade wars disrupt global supply chains and threaten economic stability.

Deep Dive

The week's Auto Shanghai 2025 showed that autonomous driving is rapidly transitioning from futuristic concept to tangible reality in China.(Click the headline to read full article.)
Chinese buyers rewriting domestic auto market
Shanghai Auto Show demonstrates that performance is no longer the sole differentiator for consumers also weighing intelligent features, in-car experiences, and brand identity.
China's int'l trade in goods, services hits 4.27 trln yuan in March
The value of China's international trade in goods and services reached 4.27 trillion yuan (US$592.57 billion) in March, up 6 percent year on year.
A 'poster child' for Chinese biopharma wins US approval for new cancer therapy
Akeso's drug to treat a rare, aggressive form of cancer highlights how Chinese bioscience is challenging the global dominance of Western drugmakers.